Trial
NCT03606642
SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
HonorHealth Research Institute
Collaborators
Boston Scientific Corporation
Condition
Coronary Artery Disease
Intervention
Dual Antiplatelet (DAPT) Therapy
Why stopped
The DSMC March 16, 2022 reviewed of Interim Analysis and recommendation due to no glaring outcomes found to date.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-27